Ellerson Group Inc /Adv / REGN
Ellerson Group Inc /Adv’s Regeneron Pharmaceuticals Position
Does Ellerson Group Inc /Adv own Regeneron Pharmaceuticals (REGN)? Yes — 8.1K shares worth $6M (+4.09% of its 13F portfolio) as of Q1 2026, up from 8.0K shares the prior filed quarter.
Position Value
$6M
Q1 2026
Shares
8.1K
% of Portfolio
+4.09%
Quarters Held
14
currently held
Position History REGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 8.1K | $6M | +4.09% |
| Q4 2025 | 8.0K | $6M | +4.20% |
| Q3 2025 | 8.1K | $5M | +2.83% |
| Q2 2025 | 5.4K | $3M | +2.01% |
| Q1 2025 | 8.1K | $5M | +4.11% |
| Q4 2024 | 6.9K | $5M | +3.60% |
| Q3 2024 | 6.9K | $7M | +5.66% |
| Q2 2024 | 7.0K | $7M | +5.59% |
| Q1 2024 | 7.1K | $7M | +5.20% |
| Q4 2023 | 7.1K | $6M | +5.41% |
| Q3 2023 | 7.1K | $6M | +5.44% |
| Q2 2023 | 7.2K | $5M | +4.95% |
| Q1 2023 | 7.1K | $6M | +6.29% |
| Q4 2022 | 7.1K | $5M | +5.40% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ellerson Group Inc /Adv’s full portfolio or all institutional holders of REGN.